$0.055
-0.008 (-15.15%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Adaptimmune Therapeutics PLC (ADAP) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting ADAP is Strong sell.
Adaptimmune Therapeutics PLC (ADAP) 20-Day simple moving average is 0.14, while Adaptimmune Therapeutics PLC (ADAP) share price is $—, making it Sell.
Adaptimmune Therapeutics PLC (ADAP) 60-Day simple moving average is 0.10, while Adaptimmune Therapeutics PLC (ADAP) share price is $—, making it Sell.
Technical Analysis for ADAP
AI Technical ADAPAs of 2025-10-27, the technical board for Adaptimmune Therapeutics PLC (ADAP) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.05 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 38.154, MACD stands at -0.0149 (Sell), Stochastic %K stands at 9.216 (Buy), Stochastic %D stands at 10.125 and CCI stands at -110.972 (Buy).
ADAP trades below the 60-day SMA (0.10) and below the 200-day SMA (0.28). Immediate resistance sits at Classic R1 0.22, then R2 0.33. Support sits at Classic S1 0.02, then S2 -0.07.
Adaptimmune Therapeutics PLC (ADAP) Support & Resistance Level
Adaptimmune Therapeutics PLC (ADAP) Technical Indicators
2025-10-27
| Name | Value |
|---|---|
| RSI_14 | 38.154 |
| STOCHk_14_3_3 | 9.216 |
| STOCHd_14_3_3 | 10.125 |
| CCI_20 | -110.972 |
| AO_5_34 | -0.063 |
| MOM_10 | -0.125 |
| MACD_12_26_9 | -0.015 |
Adaptimmune Therapeutics PLC (ADAP) Relative Strength Index (RSI_14) is 38.154, creating a Neutral signal.
Adaptimmune Therapeutics PLC (ADAP) Stochastic %K is 9.216, creating a Buy signal.
Adaptimmune Therapeutics PLC (ADAP) Stochastic %D is 10.125, creating a Buy signal.
Adaptimmune Therapeutics PLC (ADAP) CCI_20 is -110.972, creating a Buy signal.
Adaptimmune Therapeutics PLC (ADAP) Awesome Oscillator (AO) is -0.063, creating a Sell signal.
Adaptimmune Therapeutics PLC (ADAP) Momentum (MOM) is -0.125, creating a Sell signal.
Adaptimmune Therapeutics PLC (ADAP) Moving Average Convergence Divergence (MACD) is -0.015, creating a Sell signal.
Adaptimmune Therapeutics PLC (ADAP) Moving Average
2025-10-27
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.062 | Sell |
| MA_10 | 0.111 | Sell |
| MA_20 | 0.136 | Sell |
| MA_60 | 0.099 | Sell |
| MA_200 | 0.279 | Sell |
| MA_250 | 0.357 | Sell |
Adaptimmune Therapeutics PLC (ADAP) 5-Day simple moving average is 0.062, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
Adaptimmune Therapeutics PLC (ADAP) 10-Day simple moving average is 0.111, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
Adaptimmune Therapeutics PLC (ADAP) 20-Day simple moving average is 0.136, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
Adaptimmune Therapeutics PLC (ADAP) 60-Day simple moving average is 0.099, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
Adaptimmune Therapeutics PLC (ADAP) 200-Day simple moving average is 0.279, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
Adaptimmune Therapeutics PLC (ADAP) 250-Day simple moving average is 0.357, while Adaptimmune Therapeutics PLC (ADAP) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.